MarketCap
Facebook
X
Telegram
Land |
 Kanada |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
16.5 M |
Marktkapitalisierung |
$ 150 M |
EBITDA (LTM) |
$ -11.1 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-0.55 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Фармсинтез
LIFE
|
- | - | - | MOEX |  Russia |
 |
AbbVie
ABBV
|
$ 257.12 | 0.86 % | $ 455 B | NYSE,SPB |  USA |
 |
AbCellera Biologics
ABCL
|
$ 10.89 | 4.11 % | $ 3.25 B | Nasdaq Global Select Market | Canada |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market |  Britain |
 |
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | Britain |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Abeona Therapeutics
ABEO
|
$ 5.42 | 0.18 % | $ 287 M | Nasdaq Capital Market | USA |
 |
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | Israel |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Cyclerion Therapeutics
CYCN
|
$ 23.52 | 458.67 % | $ 98.9 M | Nasdaq Global Select Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 2.0 | 0.3 % | $ 726 M | Nasdaq Global Select Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 5.12 | 0.1 % | $ 981 M | Nasdaq Global Select Market | Canada |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
NextCure
NXTC
|
$ 7.0 | 0.55 % | $ 19.9 M | Nasdaq Global Select Market | USA |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 37.01 | 0.27 % | $ 1.77 T | Nasdaq Global Select Market |  France |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 27.83 | 0.32 % | $ 4.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Axcella Health
AXLA
|
- | -16.42 % | $ 249 M | Nasdaq Global Market | USA |
 |
SQZ Biotechnologies Company
SQZ
|
- | 57.95 % | $ 12.8 M | NYSE | USA |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
Achieve Life Sciences
ACHV
|
$ 7.06 | 0.41 % | $ 308 M | Nasdaq Capital Market | USA |
 |
Baudax Bio
BXRX
|
- | 0.59 % | $ 63 K | Nasdaq Capital Market | USA |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
CymaBay Therapeutics
CBAY
|
- | - | $ 3.45 B | Nasdaq Global Select Market | USA |
 |
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | USA |
 |
ChemoCentryx
CCXI
|
- | - | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
 |
Avid Bioservices
CDMO
|
- | - | $ 789 M | Nasdaq Capital Market | USA |
 |
AC Immune SA
ACIU
|
$ 2.76 | 2.6 % | $ 278 M | Nasdaq Global Market |  Schweiz |
|
Cerevel Therapeutics Holdings
CERE
|
- | - | $ 7.29 B | Nasdaq Capital Market | USA |
 |
Aclaris Therapeutics
ACRS
|
$ 5.32 | 1.27 % | $ 652 M | Nasdaq Global Select Market | USA |
 |
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | USA |
 |
Adagene
ADAG
|
$ 3.4 | 2.72 % | $ 201 M | Nasdaq Global Market |  China |
 |
ADC Therapeutics SA
ADCT
|
$ 1.07 | 0.45 % | $ 136 M | NYSE | Schweiz |
 |
Adial Pharmaceuticals
ADIL
|
$ 4.9 | 0.08 % | $ 3.28 M | Nasdaq Capital Market | USA |
 |
ADMA Biologics
ADMA
|
$ 9.23 | 0.16 % | $ 2.2 B | Nasdaq Global Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 24.2 | 0.08 % | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Agenus
AGEN
|
$ 6.94 | 0.73 % | $ 206 M | Nasdaq Capital Market | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 33.6 | 0.16 % | $ 1.95 B | Nasdaq Global Select Market,SPB | USA |